Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant PIPAC with Oxaliplatin in Resected High Risk Colon Cancer
NCT03280511Phase 2Recruiting
- Start
- Dec 2017
- Primary completion
- Oct 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in colon cancer. Started Dec 2017; status: recruiting.
02
Drugs
oxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03280511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280511.